This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Nov 14:345:e7518.

doi: 10.1136/bmj.e7518.

Commentary: Substandard medicines are the priority for neglected tropical diseases

Thomas P C Dorlo¹, Raffaella M Ravinetto, Jos H Beijnen, Marleen Boelaert

Affiliations

PMID: 23152570
DOI: 10.1136/bmj.e7518

Comment

Commentary: Substandard medicines are the priority for neglected tropical diseases

Thomas P C Dorlo et al. BMJ. 2012.

. 2012 Nov 14:345:e7518.

doi: 10.1136/bmj.e7518.

Authors

Thomas P C Dorlo¹, Raffaella M Ravinetto, Jos H Beijnen, Marleen Boelaert

Affiliation

¹ Department of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute, Amsterdam, Netherlands. thomas.dorlo@slz.nl

PMID: 23152570
DOI: 10.1136/bmj.e7518

No abstract available

PubMed Disclaimer

Comment on

How to achieve international action on falsified and substandard medicines.
Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M. Attaran A, et al. BMJ. 2012 Nov 13;345:e7381. doi: 10.1136/bmj.e7381. BMJ. 2012. PMID: 23149211 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information